Antileukotrienes as adjunctive therapy in acute asthma

Drugs

Volumn 67, Issue 12, 2007, Pages 1665-1670

  Kuitert, Lieske M E ^a   Watson, Danie ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO; PREDNISOLONE; SALBUTAMOL; TERBUTALINE; ZAFIRLUKAST;

AREA UNDER THE CURVE; ASTHMA; DRUG DOSE COMPARISON; DRUG INDUCED DISEASE; DRUG MECHANISM; EMERGENCY WARD; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RECURRENCE RISK; REVIEW; SHORT COURSE THERAPY; SINGLE DRUG DOSE;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL SPASM; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES;

EID: 34547884221     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200767120-00002     Document Type: Review

References (27)

1. O'Byrne P. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111 (2 Suppl.): S27-34
2. Laitinen LA, Laitinen A, Haahtela T, et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Science 1982; 216: 196-8
3. Wenzel SA. The role of leukotrienes in asthma. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 145-55
4. Sampson AP, Pizzichini E, Bisgaard H. Effect of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. J Allergy Clin Immunol 2003; 111 (1 Suppl.): S49-59
5. Holgate ST, Peters-Golden M, Panettieri RA, et al. Role of cysteinyl leukotrienes in airway inflammation, smooth muscle function and remodelling. J Allergy Clin Immunol 2003; 111 (1 Suppl.): S37-42
6. Barnes NC, Kuitert L. Influence of leukotriene receptor antagonists on baseline pulmonary function and asthmatic responses. Adv Prostaglandin Thromboxane Leukot Res 1994; 22: 217-26
7. Sampson AP, Green CP, Spencer DA, et al. Leukotrienes in the blood and urine of children with acute asthma. Ann N Y Acad Sci 1991; 629: 437-9
8. Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Int Med 1998; 158: 1213-20
9. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leuko-triene receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998; 339: 147-52
10. Kemp JP, Dockhorn RJ, Shapiro GG, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 1998; 133: 424-8
11. Barnes NC, Miller CJ. Effect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trials. Thorax 2000; 55: 478-83
12. van Adelsburg J, Moy J, Wei LX, et al. Safety, tolerability, and exploratory efficacy of in 6- to 24-month-old patients with asthma. Curr Med Res Op 2005; 21: 971-9
13. National Institutes of Health 2002. Global initiative for asthma: global strategy for asthma management and prevention 02-5075. Bethesda (MD): National Heart, Lung and Blood Institute: 1-178 [online]. Available from URL: http://www.ginasthma.com [Accessed 2007 Feb 21]
14. British Thoracic Society/SIGN British Guideline on the Management of Asthma November 2005 update [online]. Available from URL: http://www. enterpriseportal2.co.uk/filestore/bts/asthmaupdatenov05.pdf [Accessed 2007 Feb 21]
15. Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis: an evidence-based review. Drugs 2007; 67 (6): 887-901
16. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States 1985-1994. J Allergy Clin Immunol 2000; 106: 493-9
17. Emerman CL, Woodruff PG, Cydulka RK, et al. Prospective multicentre study of relapse following treatment for acute asthma among adults presenting to the emergency department. Chest 1999; 115: 919-27
18. Strauss L, Hejal R, Galan G, et al. Observations on the effects of aerosolised albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155: 454-8
19. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review). In: Lasserson T, Picot J, editors. Available in The Cochrane Library [database on disk and CD ROM]. Oxford: Oxford Update Software, 2001
20. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute asthma: an evidence-based evaluation. Chest 1999; 116: 285-95
21. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999; 107: 363-70
22. Hui KP, Barnes NC. Lung function improvement in asthma with cysteinyl-leukotriene receptor antagonist. Lancet 1991; 337: 1062-3
23. Dockhorn RJ, Baumgartner RA, Leff JA, et al. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000; 55: 260-5
24. Carmargo CA, Smithline HA, Malice M-P, et al. A randomised controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167: 528-33
25. Cylly A, Kara A, Ozdemir T, et al. Effects of oral montelukast on airway function in acute asthma. Respir Med 2003; 97: 533-6
26. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomised, double-blind, multicenter trial. Chest 2004; 126: 1480-9
27. Cheng H, Leff JA, Amin R, et al. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res 1996; 13: 445-8